Member Info for Saintsmith

Totally agree valju, corrupt mothers the lot of them . Let’s not get troublesome started we might spoil one of his Carboot sales with that dodgy crowd he likes to knock about with ;)
Hopeful ,from what I believe the government are giving local councils more powers and responsibility over testing and Local NHS procurement . Passing the book ?? Decentralising them selfs so to sisal .
So maybe all the new sales/ support teams are to deal with local councils and hospitals directly .
This share price is a joke but I still have full confidence that we will rerate , patience is required .

Thankfully for them the USA will not be using the dodgy innova LFT.
Unlike our own government who based on lower death rates are willing to flip the coin with its citizens health .
So maybe the Novacyt US branding will be chasing US sales for accurate LFT ?

Need our kits , damn autocorrect .
Gobble , gobble , gobble ;)

Well it’s looking good in France 11% up .

I’m probably just been greedy morning sun but I won’t get excited until we are back in double figures again ;)

Brilliant RNS though .

Great RNS indeed , other covid plays would dream for these figures . The government are already talking about a surge in flu this year , last year our winterplex test was under used due to very few cases .
This year I’d be telling the DHSC if you eat our kits , cough up what you owe us .
Nice for shareholders old and new to get a mention from GM.
I’m not sure I’m expecting this to rocket today , £5 ish maybe COB . It will however continue to climb and the mid cap £15 ambition will happen in my opinion, the wheels are in motion.
You just need patience .

Sounds like you know a very dodgy crowd troublesome .

Wasn’t aware of that b2hs2l . Thanks.

Don’t forget we were heavily involved in HPV and cervical cancer screening back in 2014 . I expect us to revisit this strategy via NPT q16 testing once we have our Q machines more in place with NHS and private companies .

Novacyt Strategy 2014

The focus of management in 2015 is to develop the infrastructure required to accelerate the commercialisation of the NOVAprep® platform initially for cervical cancer screening. The target markets will include Asia Pacific and those developed markets which have yet to convert to liquid based cytology which represents over 50% of the cervical cancer screening market. The current global cervical cancer Pap smear screening market (according to Transparency Market Research) is estimated at $3.0bn in 2014 and growing at 6.3% per annum. In Asia and other developing markets Transparency Market Research estimates the Pap screening market is growing by over 8.1% per annum. The Company therefore believes the cervical cancer screening market represents a significant opportunity for the NOVAprep® platform.

Some countries are evaluating the use of human papillomavirus (HPV) testing as the primary cervical cancer screen and in 2014 Transparency Market Research estimated the HPV testing market to be worth $624.5mn and growing at 8.3% per annum. While some parties believe HPV testing is a threat to cytology testing for cervical cancer screening, Novacyt believes the market opportunity for NOVAprep® remains strong and is growing.

@shearclass
Tom winnifred and his butches.
ADFN not to be trusted IMO

I doubt it earth , more like 5 months . The amount of days the bourse share price closed within decimal points of their ridiculous target was more than a bit of a coincidence in my opinion .

Along with the DHSC dispute , oddos inaccurate valuation of the company wiped millions off our share price . Shocking company I hope we cut all ties with those french twats.

I wouldn’t want to be a Scottish shortbread shorter tonight ;)

Halted in Paris up 20%

I also emailed most staff from gb news last night hillseeker , not heard anything back from any of them yet so will be interested to hear if you get a reply .

Share price in double figures would be nice too ;)

I have also sent this to the GB news team , feel free to use or tweak to send to any other media outlet .

Dear sirs/ madams .

May I firstly congratulate you on your new show , it is what the U.K. needs an unbiased , less politically linked broadcaster .

I’m emailing you all to make you aware of the innova lateral flow tests that our government continue to use with DHSC approval .

The accuracy of these tests are very questionable regarding sensitivity and specificity ( false positives and false negatives ) yet our government have spent over £2 billion of tax payers money on them and plan to open a new site in the U.K. mass producing them .
It may be worth you running a story on this ?

Your story may save lives .

Below are some links you may find of interest .

https://www.bmj.com/content/373/bmj.n1514

https://www.mddionline.com/covid-19/dont-use-covid-19-rapid-test-fda-warns

https://www.fda.gov/medical-devices/safety-communications/stop-using-innova-sars-cov-2-antigen-rapid-qualitative-test-fda-safety-communication

https://www.statnews.com/2021/06/10/fda-accuses-company-of-distributing-unapproved-covid-test-using-falsified-data/

I hope you at least raise awareness of this and if possible / allowed run a story as this cannot go on .

Thank you in anticipation

I have just emailed mrs Churchill .

Good work @vanv.

Surely our LFT partner is Astra Zeneca ?
Don’t forgot the saliva based trials for LFT we have recently been doing for them .
We’ve been working with them right from the start of the pandemic .

I’d take kitzies post as a no for merging with Roche kaeren. They seem to have partnered up with biosensor and will be using navify as an app to store information .